Research led by McGill University and Queen’s University Belfast has found that viruses can ‘hijack’ an existing molecular process in the cell in order to block […]
A significant number of non-Hodgkin lymphoma (NHL) patients in a Penn Medicine-initiated clinical trial continue to be in remission five years after receiving the chimeric antigen […]
Researchers from the University of Helsinki have demonstrated the possibilities of artificial intelligence-based algorithms in predicting the efficacy of a targeted cancer therapy based on the […]